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Abstract Exposure of several leukaemia cell types to the
polyamine spermine triggered caspase activation. In HL60 cells,
the onset of caspase activity correlated with the accumulation of
spermine, and was accompanied by the processing of the caspase-
3 precursor and the digestion of the substrate proteins PARP and
gelsolin. Spermine also induced the accumulation of cytochrome
c in the cytosol. Caspase activation triggered by spermine was
not blocked by antioxidants or inhibition of polyamine oxidase.
The deregulation of polyamine uptake strongly sensitised the
cells to spermine-induced caspase activation. These data show
that an excessive intracellular level of spermine triggers caspase
activation that is not mediated by oxidative mechanisms, and
suggest a model where elevated free cytosolic polyamines may
act as transducers of a death message.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The control of the intracellular polyamine pool is a highly
regulated process that involves the modulation of the synthe-
sis and activity of the key enzymes responsible for polyamine
synthesis and interconversion as well as the regulation of poly-
amine transport [1]. In fact, substantial levels of polyamines
are required for normal cell growth, but excess polyamines
elicit toxic e¡ects [2,3]. It has been known for many years
that polyamine oxidation by plasma amine oxidase may cause
cytotoxicity [4]. But more recently, oxidation-independent
mechanisms for polyamine toxicity have been found [5,6],
and several data indicate that high levels of polyamines or
their analogues can kill cells by inducing apoptosis [6^10].
Apoptosis, consisting in a regulated process of cell death, is
characterised by several biochemical events, but the central
point of the execution phase is represented by the activation
of caspase proteases [11]. Caspases are a family of cysteine
proteases responsible for many, if not all, of the character-
istics of apoptotic cell death. Caspases are synthesised as in-
active precursors, which can be activated by proteolytic cleav-
age, and receptor-linked events and/or mitochondria are
involved in this process [11].
To date, there is no information about the e¡ect of poly-
amines on caspase activity. In this paper it is reported that cell
exposure to spermine triggers caspase activation, indicating a
precise mechanism responsible for polyamine cytotoxicity.
The presented data also suggest a possible involvement of
polyamines in the transduction of a death message.
2. Materials and methods
2.1. Materials and cells
Spermine and other polyamines, Ac-DEVD-AMC, anti-gelsolin
antibody and all other biochemicals were products of Sigma. Mouse
monoclonal antibodies against caspase-3 and PARP were from Trans-
duction Laboratories and anti-cytochrome c was obtained from Phar-
mingen. Horseradish peroxidase-conjugated anti-mouse IgG from
Amersham was used as secondary antibody.
HL60, U937 and Jurkat human leukaemia cells were set up at
4U105 cells/ml in RPMI 1640 medium supplemented with 10% foetal
calf serum (20% in the case of HL60) and 100 U/ml of both penicillin
and streptomycin. L1210-DR cells, an ODC-overproducing cell line,
were maintained as previously described [12] in the presence of
DFMO, and seeded at 4U105 cells/ml for experiments. Hypo-osmotic
medium was prepared exactly as described by Poulin et al. [6,13] by
omitting NaCl from the RPMI 1640 formulation. In the course of the
experiments, the media always contained 1 mM aminoguanidine, in
order to inhibit serum amine oxidase activity [6]. Cell death was eval-
uated by trypan blue exclusion.
2.2. Determination of caspase activity
At the end of the experiment, the cells (4U105 in 1 ml of medium)
were collected, washed in phosphate-bu¡ered saline, and homogenised
in 0.1 ml of chilled lysis bu¡er. A detailed description of sample
preparation and caspase assay is given elsewhere [14]. The activity
of caspase enzymes was measured by the cleavage of the £uorogenic
peptide substrate Ac-DEVD-AMC during a 15 min incubation at
37‡C. One unit is de¢ned as the amount of enzyme activity cleaving
1.0 nmol of substrate per minute. Since the sequence DEVD repre-
sents a substrate for caspase-3 and other members of the caspase
family [15], this activity will be referred to as caspase activity.
2.3. Cleavage of caspase-3 and its substrates
At the end of the incubations, the cells (0.5^1U107) were collected,
washed once in phosphate-bu¡ered saline, suspended in lysis bu¡er
(150 mM NaCl, 0.25% sodium deoxycholate, 1% Nonidet P40, 1 mM
NaF, 1 mM EGTA, 1 mM phenylmethylsulphonyl £uoride, 1 Wg/ml
each of aprotinin, leupeptin and pepstatin) and sonicated in ice for
5 min. The homogenates were centrifuged at 28 000Ug for 10 min
and, after the determination of protein concentration, the superna-
tants were diluted in loading bu¡er and boiled for 3 min. Aliquots
corresponding to 50 Wg protein of each sample were analysed by SDS-
PAGE on a polyacrylamide gel (12% for caspase-3 or 7.5% for PARP
or gelsolin). Standard protein markers were used for molecular weight
calibration. After blotting, the nitrocellulose membrane was blocked
for 1 h with 5% non-fat milk, washed with Tris-bu¡ered saline, and
probed for 1 h with speci¢c primary antibody. After a further wash,
the membrane was incubated 30 min with the secondary antibody.
Immunoreactive bands were visualised with an enhanced chemolumi-
nescence kit (Amersham).
2.4. Determination of cytochrome c release in cytosol
The release of cytochrome c from mitochondria was examined in
cytosolic extracts obtained by subcellular fractionation. Brie£y, the
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cells (20U107) were suspended in ice-chilled bu¡er A [16] and broken
by 30 strokes with a Te£on pestle in a Pyrex homogeniser. After
centrifugation at 750Ug for 10 min, the resultant supernatant was
centrifuged at 10 000Ug for 15 min, and the supernatant recentrifuged
for 1 h at 100 000Ug to obtain a cytosolic fraction [17]. The protein
concentration was determined and, after boiling in loading bu¡er, 20
Wg protein of each sample was loaded onto a 15% polyacrylamide gel
and separated by SDS-PAGE. The content of cytochrome c was de-
termined by Western blotting followed by immunodetection and che-
moluminescence visualisation as described for caspase-3 analysis, ex-
cept that the time of incubation with the primary antibody was 30
min.
2.5. Polyamine analysis
The cells (8U105 in 2 ml of medium) were collected at the end of
the experiment and washed three times with 20-ml aliquots of ice-cold
phosphate-bu¡ered saline. The resulting pellet was resuspended in 0.4
ml of chilled 0.3 M perchloric acid and subjected to two cycles of
freeze-thawing. After centrifugation at 12 000Ug for 5 min, 0.3 ml of
the clear supernatant was used for polyamine analysis, whereas the
pellet was dissolved in 0.4 ml of 0.3 M NaOH for protein determi-
nation. Spermine and other polyamines were separated and quanti¢ed
by HPLC after derivatisation with dansyl chloride [18].
3. Results
3.1. High doses of spermine activate caspase-3
To investigate the involvement of caspase enzymes in the
cytotoxic action of polyamines, HL60 cells were exposed for
24 h to increasing concentrations of spermine in the medium.
As shown in Fig. 1, caspase activity was dose-dependently
activated by spermine at concentrations higher than 1 mM.
Spermine was much more e⁄cient than spermidine in activat-
ing caspase activity, whereas putrescine did not elicit signi¢-
cant e¡ects up to 5 mM. The onset of caspase activity paral-
leled the increase in spermine content of the cells (Fig. 1B).
Activation of the members of the caspase family involves
proteolytic cleavage of precursor proenzyme into smaller sub-
units [11]. Total cell lysates were collected after 24 h of sper-
mine or staurosporine treatment and subjected to Western
blotting analysis (Fig. 1C). Staurosporine was used as a pos-
itive control, since it rapidly induces apoptosis in all cell types.
The activation of caspase-3, as indicated by the processing of
the full-length p32 procaspase-3, was observed in either stau-
rosporine- and spermine-treated cells, and was accompanied
by the cleavage of substrate proteins PARP and gelsolin.
In some cases, the oxidation of polyamines or their ana-
logues has been implicated in induction of apoptosis [7,9,19],
but evidence also exists that polyamines may exert cytotoxic
e¡ects not mediated by their oxidation byproducts [5,6]. In
order to test the involvement of oxidative mechanisms in sper-
mine-induced caspase activation, HL60 cells were treated with
spermine alone or together with N-acetylcysteine or trolox, a
vitamin E analogue. These antioxidants, which have been
shown to inhibit apoptosis induced by oxidative stress
[20,21], did not a¡ect the action of spermine (Fig. 2). Since
H2O2 is generated by the action of PAO [22], the e¡ect of
MDL 72527, a potent irreversible inhibitor of PAO [23], was
investigated. MDL 72527 had no e¡ect alone, but dose-de-
pendently increased the activation of caspase activity by sper-
mine, in agreement with the data of Brunton et al. [5], who
reported an exacerbation of spermine toxicity in kidney cells
by MDL 72527. It is worth noting that 1 mM aminoguanidine
was always added to the media, to prevent spermine degrada-
tion by serum amine oxidase. If aminoguanidine was omitted,
caspase activation by spermine was reduced by 30^60% (not
shown). Altogether, these data show that oxidative mecha-
nisms are not involved in spermine-induced apoptosis.
3.2. Spermine causes cytochrome c release in cytosol
Previous studies have shown that accumulation of cyto-
chrome c in the cytosol occurs in response to several apoptotic
stimuli [16,24]. In order to examine whether spermine induced
the release of cytochrome c from mitochondria, HL60 cells
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Fig. 1. Spermine triggers activation of caspase-3 in HL60 leukaemia
cells. A: The cells were incubated for 24 h in the presence of the in-
dicated concentration of spermine (Spm) or other polyamines sper-
midine (Spd) or putrescine (Put), afterwards caspase activity was
measured. B: The cells were incubated for the indicated time in the
absence (control) or presence (Spm-treated) of 5 mM spermine be-
fore the assays of spermine levels and caspase activity. C: The
cleavage of procaspase-3, PARP and gelsolin was determined in
cells incubated for 24 h with none (control, lane 1), 1 WM stauro-
sporine (lane 2) or 5 mM spermine (lane 3). All the panels represent
results obtained in a typical experiment representative of more (two
to four).
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were exposed for 20 h to spermine or etoposide, a classical
inducer of apoptosis. The cytosolic S-100 fractions were then
isolated and analysed for the content of cytochrome c. Fig. 3
shows that cytosolic cytochrome c levels were increased fol-
lowing either spermine or etoposide. It should be noted that
these treatments similarly induced caspase activity in HL60
cells as well as in U937 and Jurkat leukaemia cells (Fig. 3,
bottom).
3.3. Deregulation of polyamine uptake potentiates the
caspase-activating e¡ect of spermine
A stringent control of polyamine pool size is operative in
eukaryotic cells, and increased levels of polyamines block their
uptake. However, the uptake of polyamines may be deregu-
lated in L1210-DR cells. In this ODC-overproducing cell line,
the feedback inhibition of polyamine transport is lost after
hypo-osmotic shock, with resulting accumulation when exog-
enous polyamines are provided [13]. L1210-DR cells were
hypo-osmotically stressed for 24 h, afterwards 10 WM sper-
mine or spermidine was added to the medium for 8 h. Poly-
amine addition had a dramatic e¡ect on caspase activity and
again spermine was the most powerful activator (Fig. 4). In
the absence of hypo-osmotic shock, the usual 5 mM concen-
tration of polyamines was required to activate caspase to a
comparable extent. It is worth noting that the time required to
reach maximal caspase activation by polyamines was shorter
in L1210-DR cells (8 h) than in other cell lines, such as HL60,
U937 or Jurkat (24 h) (not shown).
4. Discussion
The present data clearly show that polyamines trigger casp-
ase activation in leukaemia cells. Spermine is the stronger
activator of caspase activity, and causes the processing of
the p32 precursor of caspase-3 into the active enzyme and
the consequent digestion of PARP and gelsolin, two proteins
recognised as substrates of caspase-3 [25,26].
A prolonged exposure to high doses of exogenous spermine
is required to trigger caspase activity, in agreement with pre-
vious reports on spermine accumulation and cytotoxicity
[5,27,28]. The levels of free polyamines within the cell are
tightly regulated by means of several homeostatic mecha-
nisms. The entered polyamines are sequestered in intracellular
binding sites [3,27], furthermore, the synthesis of SSAT is
rapidly induced by polyamines, causing their acetylation and
excretion [29]. However, the main mechanism that limits the
accumulation of exogenously provided polyamines is the feed-
back inhibition of their transport [30^32]. This form of regu-
lation may be partially circumvented by using high doses of
polyamines (in the millimolar range), as we did, since in this
case polyamines may partly enter by di¡usion [27]. In this
way, within 24 h the cellular spermine content increases
more than four times, and caspase activity is largely induced
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Fig. 3. Spermine causes cytochrome c accumulation in the cytosol.
HL60 and other leukaemia cells were incubated without any treat-
ment (control), or with 10 WM etoposide or 5 mM spermine. The
content of cytochrome c in the cytosolic fraction of HL60 cells
(top) was determined after 20 h of treatment. Caspase activity in
leukaemia cell lines (bottom) was measured following 24 h of incu-
bation. The depicted data were obtained in one experiment repre-
sentative of two.
Fig. 4. E¡ect of the deregulation of polyamine uptake on caspase
activity. L1210-DR cells kept in the presence of DFMO were incu-
bated for 24 h under normo- or hypo-osmotic conditions. Thereafter
the indicated concentration of spermidine (Spd) or spermine (Spm)
was added to the medium and the incubation was continued for a
further 8 h before the determination of caspase activity. The ¢gure
reports data obtained in one experiment representative of three.
Fig. 2. E¡ect of antioxidants and inhibition of polyamine oxidase
on spermine-induced caspase activation. HL60 cells were incubated
for 24 h in the presence or absence of 5 mM spermine (Spm) to-
gether with the indicated treatments. 20 mM N-acetylcysteine
(NAC) and 100 WM trolox were added at the same time as sper-
mine. In the case of MDL 72527, the cells were preincubated for 16
h with the indicated concentrations of the PAO inhibitor before
spermine treatment. The data are means of results obtained in two
separate experiments, whose range is shown.
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(Fig. 1B). The high doses of spermine required to trigger
caspase activation, however, could raise doubts on whether
the e¡ect of spermine is a speci¢c one, or an unspeci¢c phar-
macological response. In order to answer this question, a well
known model of deregulation of polyamine uptake, repre-
sented by hypo-osmotically stressed L1210-DR cells, was
used [13]. In this system, the feedback inhibition of polyamine
uptake is lost, and intracellular spermidine levels are increased
2^3 times after exposure to low concentrations of exogenous
polyamine [6,13], causing the morphological changes typical
of apoptosis [6]. In this model, the dose of polyamines re-
quired to induce caspase activity was reduced by 500-fold,
indicating that it is the entry of polyamines, and not their
extracellular level, that triggers caspase activation. All these
data, together with the observation that caspase activation by
spermine is not inhibited by antioxidants, aminoguanidine or
a PAO inhibitor, support the hypothesis that an elevated
polyamine level per se, and not their oxidation, is responsible
for polyamine toxicity [5,6,33], and indicate a precise mecha-
nism, i.e. the activation of caspase-3 and, possibly, other
members of the caspase family.
It is worth noting that spermine causes cytochrome c accu-
mulation in the cytosolic fraction (Fig. 3). The translocation
of cytochrome c from mitochondria into the cytosol is trig-
gered by many, but not all, inducers of apoptosis [16,17,24],
and represents an important step in caspase activation [34,35].
Spermine e⁄ciently binds to mitochondria [36], and a direct
e¡ect on the release of cytochrome c could be hypothesised.
Actually, several data from our laboratory support this hy-
pothesis, and work is in progress.
In conclusion, an excess of polyamines, and particularly of
spermine, is able to trigger caspase activation. This ¢nding
reveals a direct mechanism of polyamine-induced toxicity,
and can also contribute to explain previous data [6^10], pos-
sibly including the mechanism of c-myc-induced apoptosis, in
which polyamines appear to be involved [7]. Furthermore, the
capability of spermine to cause the activation of caspase-3
suggests a possible role of polyamines in the activation of
the death programme. In fact, spermine is present in high
amounts in all eukaryotic cells, sequestered in intracellular
binding sites [3,37]. The accumulation of free spermine result-
ing from insults to anionic structures like DNA or membranes
could act as a cellular sensor of damage, transducing a death
signal.
Acknowledgements: The authors wish to thank Dr Lo Persson (Uni-
versity of Lund, Sweden) for providing L1210-DR cells, and Dr R.A.
Casero, Jr. (Johns Hopkins University, Baltimore, MD, USA) for a
gift of MDL 72527. This work was supported by grants from Italian
MURST (ex 40 and 60%) and CNR.
References
[1] Pegg, A.E. (1988) Cancer Res. 48, 759^774.
[2] Morris, R.D., Davis, R. and Co⁄no, P. (1991) J. Cell. Biochem.
46, 102^105.
[3] Davis, R., Morris, R.D. and Co⁄no, P. (1992) Microbiol. Rev.
56, 280^290.
[4] Morgan, D.M., Bachrach, U., Assaraf, Y.G., Harari, E. and
Golsner, J. (1986) Biochem. J. 236, 97^101.
[5] Brunton, V.G., Grant, M.H. and Wallace, H.M. (1991) Biochem.
J. 280, 193^198.
[6] Poulin, R., Pelletier, G. and Pegg, A.E. (1995) Biochem. J. 311,
723^727.
[7] Packham, G. and Cleveland, J.L. (1994) Mol. Cell. Biol. 14,
5741^5747.
[8] Xie, X., Tome, M.E. and Gerner, E.W. (1997) Exp. Cell Res.
230, 386^392.
[9] Hu, R.-H. and Pegg, A.E. (1997) Biochem. J. 328, 307^316.
[10] Ientile, R., Ginoprelli, T., Cannavo, G., Picerno, I. and Piedi-
monte, G. (1997) J. Neuroimmunol. 80, 87^92.
[11] Haunstetter, A. and Izumo, S. (1998) Circ. Res. 82, 1111^1129.
[12] Flamigni, F., Faenza, I., Marmiroli, S., Stanic’, I., Giaccari, A.,
Muscari, C., Stefanelli, C. and Caldarera, C.M. (1997) Biochem.
J. 324, 783^789.
[13] Poulin, R., Koward, J.K., Lakanen, J.R. and Pegg, A.E. (1993)
J. Biol. Chem. 268, 4690^4698.
[14] Stefanelli, C., Bonavita, F., Stanic’, I., Pignatti, C., Farruggia,
G., Masotti, L., Guarnieri, C. and Caldarera, C.M. (1998) Bio-
chem. J. 332, 661^665.
[15] Thornberry, N.A., Rano, T.A., Peterson, E.P., Rasper, D.M.,
Timkey, T., Garcia-Calvo, M., Houtzager, V.M., Nordstrom,
P.A., Roy, S., Vaillancourt, J.P., Chapman, K.T. and Nicholson,
D.W. (1997) J. Biol. Chem. 272, 17907^17911.
[16] Chauhan, D., Pandey, P., Ogata, A., Teoh, G., Krett, N., Hal-
gren, R., Rosen, S., Kufe, D., Kharbanda, S. and Anderson, K.
(1997) J. Biol. Chem. 272, 29995^29997.
[17] Tang, D.G., Li, L., Zhu, Z. and Joshi, B. (1998) Biochem. Bio-
phys. Res. Commun. 242, 380^384.
[18] Stefanelli, C., Carati, D. and Rossoni, C. (1986) J. Chromatogr.
375, 49^55.
[19] Parchment, R.E. (1993) Int. J. Dev. Biol. 37, 75^83.
[20] Buttke, T.M. and Sandstrom, P.A. (1994) Immunol. Today 15,
7^10.
[21] Forrest, V.J., Kang, Y.-S., McClain, D.E., Robinson, D.H. and
Ramakrishnan, N. (1994) Free Radical Biol. Med. 16, 675^684.
[22] Seiler, N. (1990) Digestion 46, 319^330.
[23] Seiler, N., Bolkenius, F.N. and Knodgen, B. (1985) Biochem.
J. 225, 219^226.
[24] Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmayer,
D.D. (1997) Science 275, 1132^1136.
[25] Cohen, G.M. (1997) Biochem. J. 326, 1^16.
[26] Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J.,
Chu, K., McGarry, T.J., Kirschner, M.W., Koths, K., Kwiatow-
ski, D.J. and Williams, L.T. (1997) Science 278, 294^298.
[27] Davis, R.H. and Ristow, J.L. (1989) Arch. Biochem. Biophys.
271, 315^322.
[28] He, Y., Kashiwagi, K., Fukuchi, J., Terao, K., Shirahata, A. and
Igarashi, K. (1993) Eur. J. Biochem. 217, 89^96.
[29] Casero Jr., R.A. and Pegg, A.E. (1993) FASEB J. 7, 653^661.
[30] Seiler, N. and Dezeure, F. (1990) Int. J. Biochem. 22, 211^218.
[31] Mitchell, J.L.A., Judd, G.G., Bareyal-Leyser, A. and Ling, S.Y.
(1994) Biochem. J. 299, 19^22.
[32] Seiler, N., Delcros, J.G. and Moulinoux, J.P. (1996) Int. J. Bio-
chem. Cell Biol. 28, 843^861.
[33] Mitchell, J.L.A., Diveley Jr., R.R., Bereyal-Leyser, A. and
Mitchell, J.L. (1992) Biochim. Biophys. Acta 1136, 136^142.
[34] Barinaga, M. (1998) Science 280, 32^34.
[35] Mignotte, B. and Vayssiere, J.L. (1998) Eur. J. Biochem. 252, 1^
15.
[36] Toninello, A., Dalla Via, L., Siliprandi, D. and Garlid, K.D.
(1992) J. Biol. Chem. 267, 18393^18397.
[37] Paulus, T.J., Cramer, C.L. and Davis, R.H. (1983) J. Biol. Chem.
258, 8608^8612.
FEBS 20998 27-10-98
C. Stefanelli et al./FEBS Letters 437 (1998) 233^236236
